Bulletin
Investor Alert

Forte Biosciences Inc.

NAS: FBRX

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 16, 2022, 6:47 p.m.

/zigman2/quotes/210207744/composite

$

1.11

Change

+0.04 +3.26%

Volume

Volume 3,219

Quotes are delayed by 20 min

/zigman2/quotes/210207744/composite

Today's close

$ 1.18

$ 1.08

Change

-0.11 -8.90%

Day low

Day high

$1.06

$1.18

Open

52 week low

52 week high

$1.06

$43.57

Open

Annual Financials for Forte Biosciences Inc.

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue 41,00018.04M---
Cost of Goods Sold (COGS) incl. D&A --11,00054,00036,000
COGS excluding D&A -----
Depreciation & Amortization Expense 292,000625,00011,00054,00036,000
Depreciation 292,000625,00011,00054,00036,000
Amortization of Intangibles -----
Gross Income --(11,000)(54,000)(36,000)
20172018201920202021 5-year trend
SG&A Expense 37.38M63.26M4.05M14.17M21.45M
Research & Development 29.11M50.46M2.67M9.95M13.82M
Other SG&A 8.27M12.81M1.38M4.22M-
Other Operating Expense -----
Unusual Expense (37,000)--32.06M61,000
EBIT after Unusual Expense (37.59M)--(46.28M)(21.55M)
Non Operating Income/Expense --(5,000)(205,000)(161,000)
Non-Operating Interest Income 595,0001.53M---
Equity in Affiliates (Pretax) -----
Interest Expense 1.93M2.94M---
Gross Interest Expense 1.93M2.94M---
Interest Capitalized -----
Pretax Income (38.93M)(47.26M)(4.07M)(46.49M)(21.71M)
Income Tax -1.7M---
Income Tax - Current Domestic -1,000---
Income Tax - Current Foreign -1.7M---
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (38.93M)(48.96M)(4.07M)(46.49M)(21.71M)
Minority Interest Expense -----
Net Income (38.93M)(48.96M)(4.07M)(46.49M)(21.71M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (38.93M)(48.96M)(4.07M)(46.49M)(21.71M)
Preferred Dividends -----
Net Income Available to Common (38.93M)(48.96M)(4.07M)(46.49M)(21.71M)
EPS (Basic) (39.90)(36.61)(1.93)(6.32)(1.55)
Basic Shares Outstanding 973,8411.34M2.11M7.36M13.97M
EPS (Diluted) (39.90)(36.61)(1.93)(6.32)(1.55)
Diluted Shares Outstanding 973,8411.34M2.11M7.36M13.97M
EBITDA (37.34M)(45.23M)(4.05M)(14.17M)(21.45M)
Link to MarketWatch's Slice.